This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
ELISA/assay
product name :
Human BCMA/TNFRSF17 DuoSet ELISA
catalog :
DY193
quantity :
1 Kit (for 15 Plates)
price :
850 USD
citations: 9
Reference
Lee H, Ahn S, Maity R, Leblay N, Ziccheddu B, Truger M, et al. Mechanisms of antigen escape from BCMA- or GPRC5D-targeted immunotherapies in multiple myeloma. Nat Med. 2023;29:2295-2306 pubmed publisher
Bolkun L, Tynecka M, Wasiluk T, Piszcz J, Starosz A, Grubczak K, et al. A Proliferation-Inducing Ligand and B-Cell Activating Factor Are Upregulated in Patients with Essential Thrombocythemia. J Clin Med. 2022;11: pubmed publisher
Visram A, Soof C, Rajkumar S, Kumar S, Bujarski S, Spektor T, et al. Serum BCMA levels predict outcomes in MGUS and smoldering myeloma patients. Blood Cancer J. 2021;11:120 pubmed publisher
Piantoni S, Regola F, Masneri S, Merletti M, Lowin T, Airo P, et al. Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Beli. Front Pharmacol. 2021;12:666971 pubmed publisher
Robinson T, Abdelhak A, Bose T, Meinl E, Otto M, Zettl U, et al. Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis. Cells. 2020;9: pubmed publisher
Perez Amill L, Suñé G, Antoñana Vildosola A, Castella M, Najjar A, Bonet J, et al. Preclinical development of a humanized chimeric antigen receptor against B cell maturation antigen for multiple myeloma. Haematologica. 2020;: pubmed publisher
Cohen A, Garfall A, Stadtmauer E, Melenhorst J, Lacey S, Lancaster E, et al. B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma. J Clin Invest. 2019;130: pubmed publisher
Schuh E, Musumeci A, Thaler F, Laurent S, Ellwart J, Hohlfeld R, et al. Human Plasmacytoid Dendritic Cells Display and Shed B Cell Maturation Antigen upon TLR Engagement. J Immunol. 2017;198:3081-3088 pubmed publisher
Thompson S, Jones J, Cox A, Compston D, Coles A. B-cell reconstitution and BAFF after alemtuzumab (Campath-1H) treatment of multiple sclerosis. J Clin Immunol. 2010;30:99-105 pubmed publisher
product information
master code :
DY193
SKU :
DY193
product name :
Human BCMA/TNFRSF17 DuoSet ELISA
unit size :
1 Kit (for 15 Plates)
description :
The Human BCMA/TNFRSF17 DuoSet ELISA from R&D Systems is a Solid Phase Sandwich ELISA that quantifies human BCMA/TNFRSF17.
target :
BCMA/TNFRSF17
category :
ELISAs
species :
Human
gene symbol :
TNFRSF17
kit type :
Solid Phase Sandwich ELISA
elisaRange :
31.20 - 2000 pg/mL
top caption :
Human BCMA/ TNFRSF17 ELISA Standard Curve
applications :
ELISA
USD :
850 USD
alt names :
B cell maturation antigen, B-cell maturation protein, BCMAtumor necrosis factor receptor superfamily member 17, BCMB-cell maturation factor, CD269, CD269 antigen, TNFRSF13A, TNFRSF17, tumor necrosis factor receptor superfamily, member 17
storage :
Store the unopened product at 2 - 8 ░C. Do not use past expiration date.
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.